APA (7th ed.) Citation

KW, G., A, O., R, K., L, J., D, H., J, H., . . . R, F. (2017). First in human trial of a type I positive allosteric modulator of alpha7-nicotinic acetylcholine receptors: Pharmacokinetics, safety, and evidence for neurocognitive effect of AVL-3288. Journal of psychopharmacology (Oxford, England), 31(4), 434. https://doi.org/10.1177/0269881117691590

Chicago Style (17th ed.) Citation

KW, Gee, et al. "First in Human Trial of a Type I Positive Allosteric Modulator of Alpha7-nicotinic Acetylcholine Receptors: Pharmacokinetics, Safety, and Evidence for Neurocognitive Effect of AVL-3288." Journal of Psychopharmacology (Oxford, England) 31, no. 4 (2017): 434. https://doi.org/10.1177/0269881117691590.

MLA (9th ed.) Citation

KW, Gee, et al. "First in Human Trial of a Type I Positive Allosteric Modulator of Alpha7-nicotinic Acetylcholine Receptors: Pharmacokinetics, Safety, and Evidence for Neurocognitive Effect of AVL-3288." Journal of Psychopharmacology (Oxford, England), vol. 31, no. 4, 2017, p. 434, https://doi.org/10.1177/0269881117691590.